Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR mutation status on brain metastases from non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands) - 1 Jun 2016

Hsu Fred, De Caluwe Alex, Anderson David, Nichol Alan, Toriumi Ted, Ho Cheryl

Abstract excerpt

OBJECTIVES: The purpose of this study was to examine the impact of EGFR mutations on the incidence of brain metastases in patients with advanced non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: A retrospective, population-based study was conducted using a provincial cancer registry to identify patients with metastatic NSCLC. Patients with diagnostic EGFR mutation testing were divided into EGFR mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to ErbB Receptors

Share to Incidence

Share to Lung Neoplasms

Share to Neoplasm Staging

Share to Protein Kinase Inhibitors

Source

Identifiers

PMID: 27133758
DOI: 10.1016/j.lungcan.2016.04.004

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR mutation status on brain metastases from non-small cell lung cancer.PMID 27133758Read ↗

Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC.Semantic proximity Read ↗

EGFR mutation status in brain metastases of non-small cell lung carcinoma.Semantic proximity Read ↗

The number of brain metastases predicts the survival of non-small cell lung cancer patients with EGFR mutation status.Semantic proximity Read ↗

EGFR mutation and brain metastasis in pulmonary adenocarcinomas.Semantic proximity Read ↗

Brain metastases in patients with EGFR-mutant non-small-cell lung cancer.Semantic proximity Read ↗

Real-world disease burden and outcomes of brain metastases in EGFR mutation-positive non-small-cell lung cancer.Semantic proximity Read ↗

Impact of EGFR Mutations on Survival and Clinical Response in Non-Small Cell Lung Cancer in a Tertiary Care Hospital.Semantic proximity Read ↗

Comparison of Prognosis Between Epidermal Growth Factor Mutation Positive and Negative Groups in Lung Adenocarcinoma Patients with Brain MetastasesSemantic proximity Read ↗

EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?Semantic proximity Read ↗

The diagnosis and treatment of brain metastases in EGFR mutant lung cancer.Semantic proximity Read ↗

Correlation of EGFR mutation subtypes and survival in surgically treated brain metastasis from non-small-cell lung cancer.Semantic proximity Read ↗

Impact of metastatic status on the prognosis of EGFR mutation‑positive non‑small cell lung cancer patients treated with first‑generation EGFR‑tyrosine kinase inhibitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.